211 related articles for article (PubMed ID: 15732111)
1. Interaction of alpha-synuclein and tau genotypes in Parkinson's disease.
Mamah CE; Lesnick TG; Lincoln SJ; Strain KJ; de Andrade M; Bower JH; Ahlskog JE; Rocca WA; Farrer MJ; Maraganore DM
Ann Neurol; 2005 Mar; 57(3):439-43. PubMed ID: 15732111
[TBL] [Abstract][Full Text] [Related]
2. Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
Mellick GD; Maraganore DM; Silburn PA
Neurosci Lett; 2005 Feb; 375(2):112-6. PubMed ID: 15670652
[TBL] [Abstract][Full Text] [Related]
3. Microtubule-associated protein tau (MAPT) influences the risk of Parkinson's disease among Indians.
Das G; Misra AK; Das SK; Ray K; Ray J
Neurosci Lett; 2009 Aug; 460(1):16-20. PubMed ID: 19450659
[TBL] [Abstract][Full Text] [Related]
4. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
Kotzbauer PT; Giasson BI; Kravitz AV; Golbe LI; Mark MH; Trojanowski JQ; Lee VM
Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854
[TBL] [Abstract][Full Text] [Related]
5. alpha-Synuclein promoter confers susceptibility to Parkinson's disease.
Pals P; Lincoln S; Manning J; Heckman M; Skipper L; Hulihan M; Van den Broeck M; De Pooter T; Cras P; Crook J; Van Broeckhoven C; Farrer MJ
Ann Neurol; 2004 Oct; 56(4):591-5. PubMed ID: 15455394
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population.
Rajput A; Vilariño-Güell C; Rajput ML; Ross OA; Soto-Ortolaza AI; Lincoln SJ; Cobb SA; Heckman MG; Farrer MJ; Rajput A
Mov Disord; 2009 Dec; 24(16):2411-4. PubMed ID: 19890971
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype.
Khan N; Graham E; Dixon P; Morris C; Mander A; Clayton D; Vaughan J; Quinn N; Lees A; Daniel S; Wood N; de Silva R
Ann Neurol; 2001 May; 49(5):665-8. PubMed ID: 11357958
[TBL] [Abstract][Full Text] [Related]
8. Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset.
Hadjigeorgiou GM; Xiromerisiou G; Gourbali V; Aggelakis K; Scarmeas N; Papadimitriou A; Singleton A
Mov Disord; 2006 Apr; 21(4):534-9. PubMed ID: 16250025
[TBL] [Abstract][Full Text] [Related]
9. Identification of a risk haplotype of the alpha-synuclein gene in Japanese with sporadic Parkinson's disease.
Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
Mov Disord; 2006 Dec; 21(12):2157-64. PubMed ID: 17078049
[TBL] [Abstract][Full Text] [Related]
10. Correlation of tau gene polymorphism with age at onset of Parkinson's disease.
Kobayashi H; Ujike H; Hasegawa J; Yamamoto M; Kanzaki A; Sora I
Neurosci Lett; 2006 Sep; 405(3):202-6. PubMed ID: 16876320
[TBL] [Abstract][Full Text] [Related]
11. Interaction between α-synuclein and tau genotypes and the progression of Parkinson's disease.
Huang Y; Rowe DB; Halliday GM
J Parkinsons Dis; 2011; 1(3):271-6. PubMed ID: 23939307
[TBL] [Abstract][Full Text] [Related]
12. The tau gene haplotype h1 confers a susceptibility to Parkinson's disease.
Zhang J; Song Y; Chen H; Fan D
Eur Neurol; 2005; 53(1):15-21. PubMed ID: 15627775
[TBL] [Abstract][Full Text] [Related]
13. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease.
Mizuta I; Satake W; Nakabayashi Y; Ito C; Suzuki S; Momose Y; Nagai Y; Oka A; Inoko H; Fukae J; Saito Y; Sawabe M; Murayama S; Yamamoto M; Hattori N; Murata M; Toda T
Hum Mol Genet; 2006 Apr; 15(7):1151-8. PubMed ID: 16500997
[TBL] [Abstract][Full Text] [Related]
14. Gene dosage and pathogenesis of Parkinson's disease.
Eriksen JL; Przedborski S; Petrucelli L
Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766
[TBL] [Abstract][Full Text] [Related]
15. Association of tau gene polymorphism with Parkinson's disease.
Zappia M; Annesi G; Nicoletti G; Serra P; Arabia G; Pugliese P; Messina D; Caracciolo M; Romeo N; Annesi F; Pasqua AA; Spadafora P; Civitelli D; Romeo N; Epifanio A; Morgante L; Quattrone A
Neurol Sci; 2003 Oct; 24(3):223-4. PubMed ID: 14600827
[TBL] [Abstract][Full Text] [Related]
16. [The alpha-synuclein gene microsatellite polymorphism and late-onset sporadic Parkinson's disease susceptibility].
Zhao XP; Zheng HM; Xie HJ; Ding SJ; Ren DM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):339-41. PubMed ID: 15300629
[TBL] [Abstract][Full Text] [Related]
17. Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease.
Winkler S; König IR; Lohmann-Hedrich K; Vieregge P; Kostic V; Klein C
Eur J Hum Genet; 2007 Nov; 15(11):1163-8. PubMed ID: 17637803
[TBL] [Abstract][Full Text] [Related]
18. [alpha-Synuclein and familial Parkinson's disease].
Iwatsubo T
No To Shinkei; 1999 Jun; 51(6):481-6. PubMed ID: 10423749
[No Abstract] [Full Text] [Related]
19. alpha-Synuclein gene and Parkinson's disease. The French Parkinson's Disease Study Group.
Science; 1998 Feb; 279(5354):1116-7. PubMed ID: 9508681
[No Abstract] [Full Text] [Related]
20. Multiple regions of alpha-synuclein are associated with Parkinson's disease.
Mueller JC; Fuchs J; Hofer A; Zimprich A; Lichtner P; Illig T; Berg D; Wüllner U; Meitinger T; Gasser T
Ann Neurol; 2005 Apr; 57(4):535-41. PubMed ID: 15786467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]